Trillions of microorganisms live in the human gut, roughly as many as there are human cells in the body.1 They produce vitamins, help regulate immunity, metabolize drugs and dietary compounds, maintain the gut barrier and signal to the brain. Diet can change this community within days, which makes it a practical target, though how much it shapes human aging is still being worked out.
The human gut microbiome — the community of bacteria, archaea, fungi, and viruses inhabiting the gastrointestinal tract — has emerged as one of the most important and most modifiable determinants of human health. The past two decades of microbiome research have established its roles in metabolic regulation, immune development, neurological function, drug metabolism, and aging. Unlike the genome (fixed at conception), the microbiome is highly responsive to diet, exercise, sleep, medications, and other lifestyle factors — making it one of the most actionable longevity targets available.1
Gut microbiome diversity — measured by metrics including alpha-diversity (within-sample species richness and evenness) — is the most consistently applied summary measure of microbiome health in both research and clinical contexts. Higher diversity reflects a more complex, resilient, and functionally redundant microbial ecosystem that provides more comprehensive metabolic services to the host. Low microbial richness is associated with obesity and markers of metabolic disease,2 and other studies link low diversity with inflammatory bowel disease and depression. Proposed mechanisms: diverse communities are more resistant to pathogen invasion (competitive exclusion), more metabolically complete (different species specialize in different substrate fermentations), and produce a wider range of bioactive metabolites that support host physiology.2
The American Gut Project, a citizen-science study with more than 10,000 participants, found that people who ate more than 30 different plant types a week had more diverse gut microbiomes than those who ate 10 or fewer.3 Variety appears to matter more than the amount of any single food, plausibly because different fibers and polyphenols feed different bacteria.
Practical implementation: count unique plant foods (different vegetables, fruits, legumes, whole grains, nuts, seeds, herbs, and spices each count separately) consumed each week. Reaching 30 requires deliberate diversification — rotating vegetables, eating legumes regularly, adding variety of whole grains, and using different herbs and spices.
The 2021 Wastyk et al. study in Cell, from Christopher Gardner's lab at Stanford, randomized 36 healthy adults to a high-fiber or a high-fermented-food diet. The fermented-food group showed increased microbiome diversity and lower levels of 19 inflammatory markers, including IL-6. The high-fiber group showed no change in diversity over the study period, and its immune responses varied between people.4 The result was unexpected and is one of the better controlled pieces of evidence for fermented foods.
Fermented foods to consider: yogurt with live cultures, kefir, unpasteurized refrigerated sauerkraut, kimchi and other fermented vegetables. In the Stanford trial, participants worked up to about six servings a day; smaller amounts have not been tested in the same way.
Akkermansia muciniphila is a gram-negative anaerobic bacterium that inhabits the mucus layer of the colon — using mucin as its primary carbon source and maintaining the integrity of the gut epithelial barrier in the process. It constitutes approximately 1-3 percent of the gut microbiome in healthy adults and is consistently reduced in obesity, metabolic syndrome, type 2 diabetes, inflammatory bowel disease, and aging. Higher Akkermansia abundance is associated with better metabolic health and lower inflammatory markers, and pasteurized Akkermansia improved metabolic markers in mice.5
In animal and small human studies, polyphenol-rich foods, omega-3 fatty acids and prebiotic fibers such as inulin have increased Akkermansia. In a pilot trial in 32 adults with overweight or obesity, three months of pasteurized Akkermansia improved insulin sensitivity by about 29% and lowered insulin and total cholesterol compared with placebo.6 It was a proof-of-concept study, and larger trials are needed.
